{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T23:34:07Z","timestamp":1784331247545,"version":"3.55.0"},"reference-count":44,"publisher":"BMJ","issue":"2","funder":[{"DOI":"10.13039\/100006436","name":"Celgene","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006436","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["RMD Open"],"accepted":{"date-parts":[[2017,12,6]]},"published-print":{"date-parts":[[2017,12]]},"abstract":"<jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>We assessed comorbidities associated with psoriatic arthritis in a broad cohort of US-insured adult patients using the Truven Health Analytics MarketScan Database.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Prevalence and incidence rates were assessed for 28 comorbid conditions among adult patients in the MarketScan database with a diagnosis of psoriatic arthritis and having two or more health claims for psoriatic arthritis between 1 July 2008 and 31 July 2015. Findings were compared with those of a similar, previously published analysis of patients with psoriasis.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Among a total of 186\u2009552 patients with a diagnosis of psoriatic arthritis, 94\u2009302 had two or more health claims for psoriatic arthritis during the study period and were included in the comorbidity analysis. The prevalence and incidence rates of the most common comorbidities were 47.5% and 35.0% for hyperlipidaemia, respectively; 47.3% and 31.3% for hypertension; 21.2% and 15.4% for depression; 20.2% and 13.5% for type 2 diabetes mellitus; and 16.6% and 12.4% for fibromyalgia. Patients with psoriatic arthritis had notably higher incidence rates of uveitis, fibromyalgia, osteoporosis, Crohn\u2019s disease and non-alcoholic liver disease than patients with psoriasis.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>This observational retrospective analysis using the MarketScan database provides real-world health claims data on the prevalence and incidence of comorbidities in a large US patient population with psoriatic arthritis. The observed high cardiometabolic comorbidity rates align with those reported in the literature and may help healthcare providers in the comprehensive management of patients with psoriatic arthritis.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/rmdopen-2017-000588","type":"journal-article","created":{"date-parts":[[2017,12,29]],"date-time":"2017-12-29T20:10:14Z","timestamp":1514578214000},"page":"e000588","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":74,"title":["Real-world burden of comorbidities in US patients with psoriatic arthritis"],"prefix":"10.1136","volume":"3","author":[{"given":"Kamal","family":"Shah","sequence":"first","affiliation":[{"name":"GPS Innovation and GPS US, EMD Serono, Billerica, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Paris","sequence":"additional","affiliation":[{"name":"Drug Safety, Celgene Corporation, Summit, New Jersey, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lillian","family":"Mellars","sequence":"additional","affiliation":[{"name":"Drug Safety, Celgene Corporation, Summit, New Jersey, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arun","family":"Changolkar","sequence":"additional","affiliation":[{"name":"GPS Innovation and GPS US, EMD Serono, Billerica, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip J","family":"Mease","sequence":"additional","affiliation":[{"name":"Swedish Medical Center and University of Washington School of Medicine, Seattle, Washington, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2017,12,28]]},"reference":[{"key":"2025090313282945000_3.2.e000588.1","doi-asserted-by":"publisher","DOI":"10.1097\/BOR.0000000000000152"},{"key":"2025090313282945000_3.2.e000588.2","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1590\/abd1806-4841.20153038","article-title":"Psoriasis: classical and emerging comorbidities","volume":"90","author":"Oliveira","year":"2015","journal-title":"An Bras Dermatol"},{"key":"2025090313282945000_3.2.e000588.3","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2010.103"},{"key":"2025090313282945000_3.2.e000588.4","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.120237"},{"key":"2025090313282945000_3.2.e000588.5","doi-asserted-by":"publisher","DOI":"10.1186\/s13063-015-1023-4"},{"key":"2025090313282945000_3.2.e000588.6","first-page":"195","article-title":"Evaluation of reporting bias in postmarketing risk assessment based on spontaneous reporting systems","volume":"23","author":"Alemayehu","year":"2009","journal-title":"Pharmaceut Med"},{"key":"2025090313282945000_3.2.e000588.7","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1002\/pst.1657","article-title":"Effect of reporting bias in the analysis of spontaneous reporting data","volume":"14","author":"Ghosh","year":"2015","journal-title":"Pharm Stat"},{"key":"2025090313282945000_3.2.e000588.8","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-200629050-00003"},{"key":"2025090313282945000_3.2.e000588.9","first-page":"211","article-title":"Patient registries: a new gold standard for\u00a0\u2018real world\u2019 research","volume":"4","author":"Trotter","year":"2002","journal-title":"Ochsner J"},{"key":"2025090313282945000_3.2.e000588.10","unstructured":"Tuven Health Analytics. Putting research data into your hands with the marketscan databases Truven Health Analytics. 2016. http:\/\/truvenhealth.com\/markets\/life-sciences\/products\/data-tools\/marketscan-databases (accessed 5 Apr 2017)."},{"key":"2025090313282945000_3.2.e000588.11","doi-asserted-by":"publisher","DOI":"10.1002\/pds.3447"},{"key":"2025090313282945000_3.2.e000588.12","doi-asserted-by":"publisher","DOI":"10.1111\/j.1475-6773.2012.01440.x"},{"key":"2025090313282945000_3.2.e000588.13","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.0000032240.28636.BD"},{"key":"2025090313282945000_3.2.e000588.14","doi-asserted-by":"crossref","DOI":"10.1186\/s12888-014-0289-5","article-title":"Systematic review and assessment of validated case definitions for depression in administrative data","volume":"14","author":"Fiest","year":"2014","journal-title":"BMC Psychiatry"},{"key":"2025090313282945000_3.2.e000588.15","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2012.04.001"},{"key":"2025090313282945000_3.2.e000588.16","doi-asserted-by":"publisher","DOI":"10.1159\/000121333"},{"key":"2025090313282945000_3.2.e000588.17","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2005.04.029"},{"key":"2025090313282945000_3.2.e000588.18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2008.08.034"},{"key":"2025090313282945000_3.2.e000588.19","doi-asserted-by":"crossref","unstructured":"Shah K , Mellars L , Changolkar A , et al . Real-world burden of comorbidities in US patients with psoriasis. J Am Acad Dermatol 2017;77:287-92.","DOI":"10.1016\/j.jaad.2017.03.037"},{"key":"2025090313282945000_3.2.e000588.20","first-page":"2167","article-title":"Cardiovascular disease and risk factors in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis","volume":"33","author":"Han","year":"2006","journal-title":"J Rheumatol"},{"key":"2025090313282945000_3.2.e000588.21","doi-asserted-by":"publisher","DOI":"10.1002\/acr.22492"},{"key":"2025090313282945000_3.2.e000588.22","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1002\/acr.20627","article-title":"Cardiovascular and other comorbidities in patients with psoriatic arthritis: a comparison with patients with psoriasis","volume":"63","author":"Husted","year":"2011","journal-title":"Arthritis Care Res"},{"key":"2025090313282945000_3.2.e000588.23","unstructured":"Centers for Disease Control and Prevention. National Diabetes Statistics Report. Atlanta, GA: Centers for Disease Control and Prevention. U.S. Department of Health and Human Services, 2017."},{"key":"2025090313282945000_3.2.e000588.24","unstructured":"Sumary Health Statistics. Table A-1. Selected circulatory diseases among adults aged 18 and over, by selected characteristics: United States, 2015. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Health Statistics. https:\/\/ftp.cdc.gov\/pub\/Health_Statistics\/NCHS\/NHIS\/SHS\/2015_SHS_Table_A-1.pdf (accessed 1 Nov 2017)."},{"key":"2025090313282945000_3.2.e000588.25","first-page":"1","article-title":"Prevalence of obesity among adults and youth: United States, 2011-2014","volume":"219","author":"Ogden","year":"2015","journal-title":"NCHS Data Brief"},{"key":"2025090313282945000_3.2.e000588.26","first-page":"1","article-title":"Total and high-density lipoprotein cholesterol in adults: United States, 2011-2014","volume":"226","author":"Carroll","year":"2015","journal-title":"NCHS Data Brief"},{"key":"2025090313282945000_3.2.e000588.27","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s12016-016-8535-x","article-title":"The inflammatory response in psoriasis: a comprehensive review","volume":"50","author":"Deng","year":"2016","journal-title":"Clin Rev Allergy Immunol"},{"key":"2025090313282945000_3.2.e000588.28","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2012.08.015"},{"key":"2025090313282945000_3.2.e000588.29","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000108926.04022.0C"},{"key":"2025090313282945000_3.2.e000588.30","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.160861"},{"key":"2025090313282945000_3.2.e000588.31","doi-asserted-by":"crossref","unstructured":"Merola JF , Herrera V , Palmer JB , et al . Comorbidity burden and medication use between psoriatic arthritis patients with moderate-to-severe psoriasis vs. those with minimal skin psoriasis in the US [poster FRI0580]. Presented at: The 2016 Annual European Congress of Rheumatology (EULAR). London, UK;\u00a08-11 June 2016.","DOI":"10.1136\/annrheumdis-2016-eular.3816"},{"key":"2025090313282945000_3.2.e000588.32","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/ker349"},{"key":"2025090313282945000_3.2.e000588.33","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.amjmed.2016.09.014","article-title":"Trends in incidence of hospitalized acute myocardial infarction in the Cardiovascular Research Network (CVRN)","volume":"130","author":"Reynolds","year":"2017","journal-title":"Am J Med"},{"key":"2025090313282945000_3.2.e000588.34","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2008.094839"},{"key":"2025090313282945000_3.2.e000588.35","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2015-207980"},{"key":"2025090313282945000_3.2.e000588.36","doi-asserted-by":"publisher","DOI":"10.2174\/138161282004140213123505"},{"key":"2025090313282945000_3.2.e000588.37","first-page":"1","article-title":"Depression in the U.S. household population, 2009-2012","volume":"172","author":"Pratt","year":"2014","journal-title":"NCHS Data Brief"},{"key":"2025090313282945000_3.2.e000588.38","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.130797"},{"key":"2025090313282945000_3.2.e000588.39","doi-asserted-by":"publisher","DOI":"10.1002\/art.23185"},{"key":"2025090313282945000_3.2.e000588.40","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1002\/art.38385","article-title":"A comparison of the malignancy incidence among patients with psoriatic arthritis and patients with rheumatoid arthritis in a large US cohort","volume":"66","author":"Gross","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"2025090313282945000_3.2.e000588.41","unstructured":"Cancer of Any Site. Statistics at a glance: National Institute of Health, surveillance, epidemiology, and end results program. 2017. https:\/\/seer.cancer.gov\/statfacts\/html\/all.html (accessed 1 Nov 2017)."},{"key":"2025090313282945000_3.2.e000588.42","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.151491"},{"key":"2025090313282945000_3.2.e000588.43","doi-asserted-by":"publisher","DOI":"10.1111\/j.0022-202X.2005.23618.x"},{"key":"2025090313282945000_3.2.e000588.44","doi-asserted-by":"publisher","DOI":"10.1097\/00005650-200201000-00005"}],"container-title":["RMD Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/rmdopen-2017-000588","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,3]],"date-time":"2025-09-03T20:28:41Z","timestamp":1756931321000},"score":1,"resource":{"primary":{"URL":"https:\/\/rmdopen.bmj.com\/lookup\/doi\/10.1136\/rmdopen-2017-000588"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":44,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2017,12,28]]},"published-print":{"date-parts":[[2017,12]]}},"alternative-id":["10.1136\/rmdopen-2017-000588"],"URL":"https:\/\/doi.org\/10.1136\/rmdopen-2017-000588","relation":{},"ISSN":["2056-5933"],"issn-type":[{"value":"2056-5933","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12]]}}}